RecruitingNot ApplicableNCT07067996

Erector Spinae Plane Block for Analgesia During ESWL


Sponsor

Sohag University

Enrollment

60 participants

Start Date

Jun 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy


Eligibility

Min Age: 21 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Nalbuphine and a procedure called erector spinae plane block for people with renal stone. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREerector spinae plane block

erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

DRUGNalbuphine

Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy


Locations(1)

Sohag University Hospital

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07067996


Related Trials